These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7210699)

  • 41. Characterization of a microsomal fraction from rat small intestine for metabolic activation of some promutagens.
    Walters JM; Combes RD
    Carcinogenesis; 1985 Oct; 6(10):1415-20. PubMed ID: 4042271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
    Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS
    Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activation of the promutagens 2-acetamidofluorene, cyclophosphamide and 7,12-dimethylbenzanthracene by constitutive ferret and rat hepatic S-9 fractions.
    Frederick KA; Babish JG
    Toxicology; 1984 May; 31(1):73-86. PubMed ID: 6427977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of disulfiram on mutagenicity of the urinary metabolites of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the Salmonella test system.
    El-Torkey NM; Weisburger EK
    Mutat Res; 1983 Jul; 118(1-2):1-6. PubMed ID: 6346083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic activation of promutagens, detectable in Ames' Salmonella assay, by 5000 X g supernatant of rat ventral prostate.
    Söderkvist P; Busk L; Toftgård R; Gustafsson JA
    Chem Biol Interact; 1983 Sep; 46(2):151-63. PubMed ID: 6354489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction and modification of rat liver microsomal arylamide N-hydroxylase by various pretreatments.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Mol Pharmacol; 1982 Mar; 21(2):449-57. PubMed ID: 7099145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9.
    Johnson TE; Umbenhauer DR; Galloway SM
    Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Developmental pattern of 3-methylcholanthrene-inducible mutagenic activation of N-2-fluorenylacetamide, 2-fluorenamine, and 2,4-diaminoanisole in the rabbit.
    Aune T; Dybing E; Thorgeirsson SS
    J Natl Cancer Inst; 1980 Apr; 64(4):765-9. PubMed ID: 6928989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
    Raina V; Williams CJ; Gurtoo HL
    Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic formation of pyrenequinones as enhancing agents of mutagenicity in Salmonella.
    Okamoto H; Yoshida D
    Cancer Lett; 1981 Jan; 11(3):215-20. PubMed ID: 7018664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics of N- and C-hydroxylations of 2-acetylaminofluorene in male Sprague-Dawley rat liver microsomes: implications for carcinogenesis.
    McManus ME; Minchin RF; Sanderson N; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1983 Aug; 43(8):3720-4. PubMed ID: 6861141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of aminothiols in 2-acetylaminofluorene-treated rats. III. Metabolic activation of aromatic amines.
    De Flora S; Camoirano A; Bennicelli C; Orunesu M; Cesarone CF
    In Vivo; 1987; 1(2):101-7. PubMed ID: 2979769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dietary modulation of phase 1 and phase 2 activities with benzo(a)pyrene and related compounds in the intestine but not the liver of the channel catfish, Ictalurus punctatus.
    James MO; Altman AH; Morris K; Kleinow KM; Tong Z
    Drug Metab Dispos; 1997 Mar; 25(3):346-54. PubMed ID: 9172953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 56. Mutagenicity-enhancing effect of quercetin on the active metabolites of 2-acetylaminofluorene with mammalian metabolic activation systems.
    Ogawa S; Hirayama T; Tokuda M; Hirai K; Fukui S
    Mutat Res; 1987 Apr; 190(4):241-6. PubMed ID: 3550450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody inhibition of oxidative activation and inactivation of the carcinogen 2-acetylaminofluorene by purified hepatic cytochrome P-450 from 3-methylcholanthrene pretreated rats.
    Pandey RN; Clearfield MS; Paik SM; Lotlikar PD
    Cancer Lett; 1983 Jul; 19(3):263-71. PubMed ID: 6411328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic activation of trp-P-2, a mutagenic amine from tryptophan-pyrolysate, by liver microsomes from 3-methylcholanthrene-responsive and non-responsive mice.
    Yamazoe Y; Yamaguchi N; Kamataki T; Kato R
    Xenobiotica; 1980; 10(7-8):483-94. PubMed ID: 7445519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific labelling of microsomal proteins by reactive intermediates generated from 2-acetylaminofluorene in vitro.
    Kaderbhai MA; Bradshaw TK; Freedman RB
    Chem Biol Interact; 1981 Aug; 36(2):211-27. PubMed ID: 7273244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgen-dependent renal microsomal cytochrome P-450 responsible for N-hydroxylation and mutagenic activation of 3-methoxy-4-aminoazobenzene in the BALB/c mouse.
    Degawa M; Miura S; Hashimoto Y
    Cancer Res; 1990 May; 50(9):2729-33. PubMed ID: 2328499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.